Proteome Sciences (LON:PRM) Trading Down 18.5% – Time to Sell?

Shares of Proteome Sciences plc (LON:PRM) were down 18.5% on Friday . The stock traded as low as GBX 2.89 ($0.04) and last traded at GBX 2.89 ($0.04). Approximately 1,014,536 shares were traded during mid-day trading, an increase of 367% from the average daily volume of 217,283 shares. The stock had previously closed at GBX 3.55 ($0.05).

Proteome Sciences Stock Performance

The company has a quick ratio of 0.37, a current ratio of 0.20 and a debt-to-equity ratio of -258.66. The stock has a market capitalization of £9.61 million, a P/E ratio of -2.36 and a beta of 0.07. The business has a fifty day moving average price of GBX 4.06 and a 200-day moving average price of GBX 3.46.

Proteome Sciences (LON:PRM) last posted its earnings results on Thursday, April 10th. The company reported GBX (1.15) (($0.01)) earnings per share (EPS) for the quarter. Proteome Sciences had a negative net margin of 0.04% and a negative return on equity of 0.01%.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.